STOCK TITAN
  1. Home
  2. News
  3. ELAN

Elanco Animal Health Inc - ELAN STOCK NEWS

Welcome to our dedicated news page for Elanco Animal Health (Ticker: ELAN), a resource for investors and traders seeking the latest updates and insights on Elanco Animal Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Elanco Animal Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Elanco Animal Health's position in the market.

News
Kirk McDonald Appointed to Ziff Davis Board of Directors
Rhea-AI Summary
Ziff Davis, Inc. (NASDAQ: ZD) appoints Kirk McDonald to its Board of Directors, effective November 15, 2023. McDonald, a highly accomplished executive with extensive experience in media, technology, and advertising, will bring valuable business leadership to Ziff Davis. He currently serves as CEO of GroupM North America and will leave the role at year end. With a career spanning over three decades, McDonald has held executive level leadership roles at prominent companies such as Warner Media's Xandr, Pubmatic, Time Inc., the Aquantive division of Microsoft, and CNET Networks. He also serves on the board of Elanco (NYSE: ELAN) and is a founding member of the Black Executive CMO Alliance. Kirk McDonald is widely respected in the industry and known for his leadership and innovation in the media and advertising ecosystem.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.87%
Tags
management
-
News
Elanco Animal Health Reports Third Quarter 2023 Results
Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) reported revenue of $1,068 million for the third quarter of 2023, representing 4% reported growth or 5% excluding the impact of foreign exchange rates. Reported Net Loss was $1,096 million, inclusive of a non-cash goodwill impairment charge of $1,042 million primarily related to increased long-term treasury rates. Adjusted EBITDA was $214 million, or 20.0% of Revenue. Updating full year 2023 guidance to reflect third quarter outperformance offset by expected unfavorable impact of foreign exchange rates: Revenue of $4,360 to $4,400 million, constant currency growth improves to flat to 1%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.32%
Tags
earnings
-
News
Athian and Elanco Animal Health Team Up to Transform Food Production through Methane Reduction
Rhea-AI Summary
Athian announces the establishment of the first voluntary livestock carbon insetting marketplace, allowing farmers to monetize their greenhouse gas emission reductions. The marketplace will focus on reducing enteric methane emissions and improving feed utilization. Dairy farmers can implement sustainability interventions, measure their impact, and sell carbon credits. Companies in the dairy value chain can purchase these credits to contribute to their emissions reduction goals. The marketplace will expand to other livestock and poultry in the future.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.57%
Tags
none
News
Elanco Confirms Date and Conference Call for Third Quarter 2023 Financial Results Announcement
Rhea-AI Summary
Elanco Animal Health to announce Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.82%
Tags
earnings
-
News
Elanco Announces Corporate Governance Enhancements
Rhea-AI Summary
Elanco Animal Health Incorporated is initiating a comprehensive governance review and seeking shareholder approval for amendments to its corporate governing documents at the 2024 Annual Meeting of Shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none
-
News
Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease
Rhea-AI Summary
Elanco Animal Health announces first shipments of Varenzin-CA1, the first treatment for non-regenerative anemia in cats with chronic kidney disease, are shipping to veterinary clinics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
none
News
Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Rhea-AI Summary
Elanco Animal Health to attend Morgan Stanley conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
conferences
-
News
Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance
Rhea-AI Summary
ELAN: Elanco Animal Health Inc. Reports Q2 2023 Financial Results, Raises Full Year Guidance. Revenue at $1,057 million, with a net loss of $(97) million. Adjusted EBITDA at $222 million. Full year 2023 revenue guidance raised to $4,350 to $4,410 million. Positive EPA resolution on Seresto. Financial results impacted by ERP system commercial ordering blackout period for legacy Bayer Animal Health products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.03%
Tags
earnings
-
News
Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations
Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE:ELAN) released its 2022 ESG Report, demonstrating commitment to ESG-related topics across its Healthy Purpose™ Pillars. The report highlights impactful initiatives such as reducing CO2e emissions by 7.2 million metric tons through the use of Rumensin™ and advancing diversity, equity, and inclusion efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.12%
Tags
none
News
Elanco Confirms Date and Conference Call for Second Quarter 2023 Financial Results Announcement
Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) to announce Q2 2023 financial results on August 7, 2023. Conference call to provide detailed performance review. Live webcast available on Elanco's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
earnings
Stock ELAN logo
Elanco Animal Health Inc

Nasdaq:ELAN

ELAN Rankings

#1041 Ranked by Market Cap
#4001 Ranked by Stock Gains
N/A Ranked by Dividends

ELAN Stock Data

7.07B
490.51M
0.65%
99.15%
2.53%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Indianapolis

About ELAN

elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.